Vericel Stock (NASDAQ: VCEL) stock price, news, charts, stock research, profile.
Open | $48.21 |
Close | $46.57 |
Volume / Avg. | 1.06M / 353.89K |
Day Range | $46.44 - $48.41 |
52 Wk Range | 30.18 - 54.10 |
Market Cap | $2.28B |
P/E Ratio | 4.80K |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 11.01% |
Days to Cover | 13.08 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vericel (NASDAQ:VCEL) through any online brokerage.
Other companies in Vericel’s space includes: SpringWorks Therapeutics (NASDAQ:SWTX), Protagonist Therapeutics (NASDAQ:PTGX), Agios Pharmaceuticals (NASDAQ:AGIO), Arrowhead Pharma (NASDAQ:ARWR) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
Vericel has a consensus price target of $50.64.
The stock price for Vericel (NASDAQ: VCEL) is $46.57 last updated September 20, 2024 at 4:39 PM EDT.
There are no upcoming dividends for Vericel.
Vericel’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Vericel.
Vericel is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.